NIH-funded research NIH-funded research

Understanding how autism and schizophrenia risk genes affect brain development

Official title: Highly Parallel Analysis of High-Confidence ASD and Schizophrenia Risk Gene Mechanisms

Funded at University of California Los Angeles · NIH-11606500 · Data updated 2026-11-12

Scientists are testing how mutations in certain autism and schizophrenia risk genes change brain cells and networks, using patient-derived cells and organoids.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startAugust 17, 2026
Project endAugust 16, 2027
Funding year2026
Award (this year)$772,569
NIH project number1R56MH143740-01
Project IDNIH-11606500 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with or at risk for autism spectrum disorder or related neuropsychiatric conditions who may contribute genetically characterized cell lines or samples.

Less likely to help

The study uses lab-grown cells and organoids and does not involve direct patient participation or treatment.

What this research studies

This project uses a scalable system of human iPSC-derived neurons and 3D cortical organoids to study about 50 risk genes linked to autism and schizophrenia. Researchers will create mutant and control cell lines, turn them into 2D neuron cultures, and use high-content imaging to look at growth and cell shape. They will also measure gene activity with RNA sequencing, analyze protein changes, and monitor neural activity to see how mutations disrupt networks in the brain. The goal is to find shared dysfunctions across disorders that could guide future therapies.

Why it matters

Potential benefit: If successful, the work could highlight common pathways disrupted in autism and related conditions, informing future targeted therapies.

How similar studies have gone: Previous studies using patient-derived neurons and organoids have revealed meaningful disease mechanisms, supporting the validity of this approach.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Yang, Xiangdong William — University of California Los Angeles
  • Study coordinator: Yang, Xiangdong William

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.